US4879236A
(en)
*
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
JPS619288A
(ja)
*
|
1984-06-21 |
1986-01-16 |
Dai Ichi Seiyaku Co Ltd |
ペプチド類の製法
|
IL80529A0
(en)
*
|
1985-11-14 |
1987-02-27 |
Daiichi Seiyaku Co |
Method of producing peptides
|
JPS63167797A
(ja)
*
|
1985-12-18 |
1988-07-11 |
マイクロジエネシス,インコ−ポレイテイド |
選択された昆虫宿主細胞中で選択されたポリペプチドを製造する方法
|
IL83003A
(en)
|
1986-07-01 |
1995-07-31 |
Genetics Inst |
Factors that soak bone formation
|
GR871029B
(en)
|
1986-07-14 |
1987-11-02 |
Genetics Inst |
Novel osteoinductive factors
|
NZ221702A
(en)
*
|
1986-09-08 |
1989-02-24 |
Bishop David H L |
Expression of human hepatitis b antigens in insects and cultured insect cells using recombinant baculoviruses
|
ZA876696B
(en)
*
|
1986-09-09 |
1988-05-25 |
Genetics Inst |
Method for producing a heterologous protein in insect cells
|
US5071748A
(en)
*
|
1986-09-09 |
1991-12-10 |
Genetics Institute, Inc. |
Mixed baculovirus compositions and uses thereof
|
US5041379A
(en)
*
|
1987-03-16 |
1991-08-20 |
American Biogenetic Science, Inc. |
Heliothis expression systems
|
US5024947A
(en)
*
|
1987-07-24 |
1991-06-18 |
Cetus Corporation |
Serum free media for the growth on insect cells and expression of products thereby
|
US5578468A
(en)
*
|
1987-08-10 |
1996-11-26 |
Duke University |
Site-specific RNA cleavage
|
US5443964A
(en)
*
|
1987-08-10 |
1995-08-22 |
Duke University |
Poxvirus insertion/expression vector
|
GB8810808D0
(en)
*
|
1988-05-06 |
1988-06-08 |
Wellcome Found |
Vectors
|
JP2511494B2
(ja)
*
|
1988-05-12 |
1996-06-26 |
善治 松浦 |
日本脳炎ウイルス表面抗原蛋白質の製造法
|
JPH0221955A
(ja)
*
|
1988-07-07 |
1990-01-24 |
Nippon Steel Corp |
流体噴射ノズル
|
SE8802939D0
(sv)
*
|
1988-08-19 |
1988-08-19 |
Kabigen Ab |
A method for the production and isolation of a fusion protein in eukaryotic cells
|
US5811523A
(en)
|
1988-11-10 |
1998-09-22 |
Trinchieri; Giorgio |
Antibodies to natural killer stimulatory factor
|
WO1990005783A1
(en)
*
|
1988-11-18 |
1990-05-31 |
Cetus Corporation |
Insect signal peptide mediated secretion of recombinant proteins
|
US5244805A
(en)
*
|
1989-05-17 |
1993-09-14 |
University Of Georgia Research Foundation, Inc. |
Baculovirus expression vectors
|
WO1993009229A1
(en)
|
1991-11-04 |
1993-05-13 |
Genetics Institute, Inc. |
Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
|
DK0698094T3
(da)
|
1993-05-12 |
2004-05-03 |
Inst Genetics Llc |
BMP-11-sammensætninger
|
US6027919A
(en)
|
1993-12-07 |
2000-02-22 |
Genetics Institute, Inc. |
BMP-12 and BMP-13 proteins and DNA encoding them
|
CA2179394A1
(en)
|
1993-12-23 |
1995-06-29 |
Kostas Iatrou |
Methods of expressing proteins in insect cells and methods of killing insects
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US6165748A
(en)
|
1997-07-11 |
2000-12-26 |
Genetics Institute, Inc. |
Frazzled nucleotide sequences and expression products
|
ATE505478T1
(de)
|
1997-08-27 |
2011-04-15 |
Novartis Vaccines & Diagnostic |
Molekular-mimetika von meningokokkalen b epitopen
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
DE69941567D1
(de)
|
1998-01-14 |
2009-12-03 |
Novartis Vaccines & Diagnostic |
Antigene aus neisseria meningitidis
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
CN101293920B
(zh)
|
1998-05-01 |
2012-07-18 |
诺华疫苗和诊断公司 |
脑膜炎奈瑟球菌抗原和组合物
|
EP1121437B1
(en)
|
1998-10-15 |
2008-02-20 |
Novartis Vaccines and Diagnostics, Inc. |
Metastatic breast and colon cancer regulated genes
|
AU2367600A
(en)
|
1998-12-16 |
2000-07-03 |
Chiron Corporation |
Human cyclin-dependent kinase ((hpnqalre))
|
NZ530640A
(en)
|
1999-04-30 |
2006-06-30 |
Chiron S |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
JP2003527833A
(ja)
|
1999-10-14 |
2003-09-24 |
クロンテック・ラボラトリーズ・インコーポレーテッド |
花虫類に由来する発色団/蛍光体、およびそれらの使用法
|
AU784203B2
(en)
|
1999-10-29 |
2006-02-23 |
Glaxosmithkline Biologicals S.A. |
Neisserial antigenic peptides
|
EP1985701B1
(en)
|
2000-01-10 |
2012-05-30 |
Novartis Vaccines and Diagnostics, Inc. |
Genes differentially expressed in breast cancer
|
RU2279889C2
(ru)
|
2000-01-17 |
2006-07-20 |
Чирон С.Р.Л. |
ВАКЦИНА ВЕЗИКУЛ НАРУЖНЫХ МЕМБРАН (OMV), СОДЕРЖАЩАЯ БЕЛКИ НАРУЖНОЙ МЕБРАНЫ N.Meningitidis СЕРОЛОГИЧЕСКОЙ ГРУППЫ В
|
US6689599B1
(en)
|
2000-10-20 |
2004-02-10 |
Genetics Institute, Llc |
Aggrecanase molecules
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
TWI329129B
(en)
|
2001-02-08 |
2010-08-21 |
Wyeth Corp |
Modified and stabilized gdf propeptides and uses thereof
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
AU2002258728A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
AU2002305151A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
AU2002319703A1
(en)
|
2001-07-27 |
2003-02-17 |
Wyeth |
Aggrecanase molecules
|
JP4413617B2
(ja)
|
2001-12-12 |
2010-02-10 |
カイロン ソチエタ ア レスポンサビリタ リミタータ |
Chlamydiatrachomatisに対する免疫化
|
JP4700281B2
(ja)
|
2001-12-19 |
2011-06-15 |
ザ・ユニバーシティ・オブ・シカゴ |
急速に成熟する蛍光タンパク質およびその使用法
|
US7078217B2
(en)
|
2002-01-31 |
2006-07-18 |
Wyeth |
Aggrecanase molecules
|
AU2003215070A1
(en)
|
2002-02-05 |
2003-09-02 |
Wyeth |
Truncated aggrecanase molecules
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
AU2003243316A1
(en)
|
2002-05-24 |
2003-12-12 |
Nps Allelix Corp. |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
AU2003239865A1
(en)
|
2002-05-24 |
2003-12-12 |
Restoragen Inc. |
Method for universal enzymatic production of bioactive peptides
|
AU2003288660A1
(en)
|
2002-11-15 |
2004-06-15 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
EP2374471A1
(en)
|
2003-09-12 |
2011-10-12 |
Wyeth LLC |
Injectable hardenable calcium phosphate pastes for delivery of osteogenic proteins
|
SI1704234T1
(sl)
|
2003-11-21 |
2012-08-31 |
Nps Pharma Inc |
Proizvodnja glukagonu podobnih peptidov 2 in analogov
|
CA2553040A1
(en)
|
2004-02-02 |
2005-08-18 |
Ambrx, Inc. |
Modified human four helical bundle polypeptides and their uses
|
US8268324B2
(en)
|
2004-03-29 |
2012-09-18 |
Galpharma Co., Ltd. |
Modified galectin 9 proteins and use thereof
|
US7250298B2
(en)
|
2004-04-07 |
2007-07-31 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
CN102603895B
(zh)
|
2004-06-18 |
2016-09-28 |
Ambrx公司 |
新颖抗原结合多肽和其用途
|
KR20070090023A
(ko)
|
2004-12-22 |
2007-09-04 |
암브룩스, 인코포레이티드 |
변형 인간 성장 호르몬
|
US7385028B2
(en)
|
2004-12-22 |
2008-06-10 |
Ambrx, Inc |
Derivatization of non-natural amino acids and polypeptides
|
KR101447897B1
(ko)
|
2005-03-21 |
2014-10-07 |
비로베이, 인코포레이티드 |
시스테인 단백질분해효소 억제제로서의 알파 케토아미드화합물
|
EP3214095B1
(en)
|
2005-05-12 |
2019-12-11 |
ZymoGenetics, Inc. |
Compositions and methods for modulating immune responses
|
US7749704B2
(en)
|
2005-11-01 |
2010-07-06 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the BLyS gene and use in diagnostic methods
|
KR20080079643A
(ko)
|
2005-11-16 |
2008-09-01 |
암브룩스, 인코포레이티드 |
비-천연 아미노산을 포함하는 방법 및 조성물
|
US20100015168A1
(en)
|
2006-06-09 |
2010-01-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
EP2069396B1
(en)
|
2006-09-08 |
2015-10-21 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
CN104163864B
(zh)
|
2007-03-30 |
2017-08-01 |
Ambrx公司 |
经修饰fgf‑21多肽和其用途
|
AU2008308509B2
(en)
|
2007-10-04 |
2014-10-23 |
Zymogenetics, Inc. |
B7 family member zB7H6 and related compositions and methods
|
WO2009059305A2
(en)
|
2007-11-01 |
2009-05-07 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
MX338336B
(es)
|
2007-11-20 |
2016-04-07 |
Ambrx Inc |
Polipeptidos de insulina modificados y sus usos.
|
WO2009073511A2
(en)
|
2007-11-30 |
2009-06-11 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the blys gene and use in diagnostic methods
|
CN101939443B
(zh)
|
2008-02-08 |
2014-01-29 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
PT2318029T
(pt)
|
2008-07-23 |
2018-01-10 |
Ambrx Inc |
Polipéptidos de g-csf bovino modificados e suas utilizações
|
ES2660000T3
(es)
|
2008-09-26 |
2018-03-20 |
Ambrx, Inc. |
Vacunas y microorganismos dependientes de la replicación de aminoácidos no naturales
|
EP2342223B1
(en)
|
2008-09-26 |
2017-04-26 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
EP2333074A1
(en)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substances and methods for the treatment of lysosmal storage diseases
|
US20120283171A1
(en)
|
2009-12-21 |
2012-11-08 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
SG181769A1
(en)
|
2009-12-21 |
2012-07-30 |
Ambrx Inc |
Modified porcine somatotropin polypeptides and their uses
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
PL2605789T3
(pl)
|
2010-08-17 |
2019-11-29 |
Ambrx Inc |
Zmodyfikowane polipeptydy relaksyny i ich zastosowania
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
WO2013014294A2
(en)
|
2011-07-27 |
2013-01-31 |
Genethon |
Improved baculovirus expression systems
|
DK3044231T3
(da)
|
2013-09-12 |
2020-09-07 |
Biomarin Pharm Inc |
Aav-vektorer, der omfatter en genkodningsfaktor viii primær anmodning
|
KR20240024362A
(ko)
|
2014-10-24 |
2024-02-23 |
브리스톨-마이어스 스큅 컴퍼니 |
변형된 fgf-21 폴리펩티드 및 그의 용도
|
RU2020126034A
(ru)
|
2015-09-24 |
2020-09-02 |
Байомарин Фармасьютикал Инк. |
Векторы фактора fviii на основе аденоассоциированных вирусов, соответствующие вирусные частицы и содержащие их терапевтические композиции
|
TN2018000163A1
(en)
|
2015-11-12 |
2019-10-04 |
Res Inst Nationwide Childrens Hospital |
Methods of treating muscular dystrophy
|
SG11201811603WA
(en)
|
2016-07-26 |
2019-02-27 |
Biomarin Pharm Inc |
Novel adeno-associated virus capsid proteins
|
SG10201912034UA
(en)
|
2017-02-08 |
2020-02-27 |
Bristol Myers Squibb Co |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
EP3688014A4
(en)
|
2017-09-29 |
2020-09-16 |
Massachusetts Eye and Ear Infirmary |
PRODUCTION OF ADENO-ASSOCIATED VIRUSES IN INSECT CELLS
|
EP3790627A2
(en)
|
2018-05-09 |
2021-03-17 |
BioMarin Pharmaceutical Inc. |
Methods of treating phenylketonuria
|
KR20210008491A
(ko)
|
2018-05-14 |
2021-01-22 |
바이오마린 파머수티컬 인크. |
청소년 대상체에서 aav 벡터의 안정한 발현
|
TW202005978A
(zh)
|
2018-05-14 |
2020-02-01 |
美商拜奧馬林製藥公司 |
新穎肝靶向腺相關病毒載體
|
EP3969061A1
(en)
|
2019-05-14 |
2022-03-23 |
BioMarin Pharmaceutical Inc. |
Methods of redosing gene therapy vectors
|
KR20220066164A
(ko)
|
2019-09-27 |
2022-05-23 |
바이오마린 파머수티컬 인크. |
크기 배제 크로마토그래피 및 다각도 광 산란 기술을 사용한 유전자 치료 바이러스 입자의 특성화
|
EP4058475A1
(en)
|
2019-11-14 |
2022-09-21 |
BioMarin Pharmaceutical Inc. |
Treatment of hereditary angioedema with liver-specific gene therapy vectors
|
US20230075854A1
(en)
|
2020-02-10 |
2023-03-09 |
Biomarin Pharmaceutical Inc. |
Virus-free cell cultures
|
WO2021183895A1
(en)
|
2020-03-13 |
2021-09-16 |
Biomarin Pharmaceutical Inc. |
Treatment of fabry disease with aav gene therapy vectors
|
AR122409A1
(es)
|
2020-04-03 |
2022-09-07 |
Biomarin Pharm Inc |
Tratamiento de la fenilcetonuria con aav y formulaciones terapéuticas
|
WO2021236908A2
(en)
|
2020-05-20 |
2021-11-25 |
Biomarin Pharmaceutical Inc. |
Use of regulatory proteins for the production of adeno-associated virus
|
JP2023548067A
(ja)
|
2020-11-02 |
2023-11-15 |
バイオマリン ファーマシューティカル インコーポレイテッド |
アデノ随伴ウイルスを濃縮するためのプロセス
|
EP4408481A2
(en)
|
2021-10-01 |
2024-08-07 |
BioMarin Pharmaceutical Inc. |
Treatment of hereditary angioedema with aav gene therapy vectors and therapeutic formulations
|
TW202421788A
(zh)
|
2022-09-22 |
2024-06-01 |
美商拜奧馬林製藥公司 |
用aav基因療法載體治療致心律不整性心肌病
|
TW202417631A
(zh)
|
2022-09-22 |
2024-05-01 |
美商拜奧馬林製藥公司 |
用aav基因治療載體治療心肌病
|
WO2024151568A1
(en)
|
2023-01-09 |
2024-07-18 |
Biomarin Pharmaceutical Inc. |
Epigenetic modifiers improve aav gene therapy durability
|